Oncology
 |
|
9 december 2022 16:25:33 |
| Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial (Radiation Oncology) |
|
Tweet For patients with a higher burden of localized prostate cancer, radiation dose escalation with brachytherapy boosts have improved cancer control outcomes at the cost of urinary toxicity. We hypothesize that a ... |
| 99 viewsCategory: Oncology |
 Speckle-type POZ protein could play a potential inhibitory role in human renal cell carcinoma (BMC Cancer)HPV vaccination leads to decrease of anogenital warts and precancerous lesions of the cervix uteri in young women with low vaccination rates: a retrospective cohort analysis (BMC Cancer) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
